UF Health: Timing, Consistency of Activity Linked to Better Fitness
A new UF study, funded by the NIA, shows that the timing and consistency of daily activity may be associated with improved cardiorespiratory fitness and walking efficiency — two key indicators of healthy aging
Water Researchers Develop Prediction System for Harmful Algae
UF researchers have developed a next-day prediction model for harmful algal blooms, providing water managers with timely tools to mitigate environmental and public health risks.
Will Genome Modifications Define Next-Gen AAV Vectors?
UF researcher Arun Srivastava, Ph.D., a gene therapy pioneer, shares his expert perspective on genome-modified AAV vectors, offering insights into how next-generation viral therapies may be shaped by precision genetic engineering.
Atsena Therapeutics Announces Positive Clinical Data From Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis (XLRS)
UF startup Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Dalir Joins National Effort To Enable 3D Optical Packaging for Next-Gen AI Chips
UF researcher Hamed Dalir, Ph.D., is collaborating on a $5.2 million federally funded project to develop a transformative 3D optical packaging platform that enables scalable, high-bandwidth, energy-efficient chip-to-chip optical communication.
UF Audio Deepfakes Study Could Ultimately Help Hearing-Impaired Detect Fraud
UF researchers found that cochlear implant users are more vulnerable to audio deepfakes, highlighting the need for better detection systems to protect the hearing-impaired from potential fraud.
Seeding Exploration
UF researchers Rob Ferl and Anna-Lisa Paul are advancing space agriculture by successfully growing plants in lunar soil, a breakthrough that supports the future of human space exploration.
The Conversation: Researchers Uncovered Hundreds of Genes Linked to OCD, Providing Clues About How It Changes the Brain
UF researchers Carol Mathews contribute to a groundbreaking international study uncovering genetic factors linked to Obsessive-Compulsive Disorder, paving the way for enhanced understanding and treatment of the condition.
UF Scientists Join European Effort To Develop Antiviral Drugs for Future Pandemics
UF researchers have joined a European research network that aims to develop broad-spectrum antiviral drugs to combat the next global pandemic.
Genascence Phase 1b DONATELLO Trial Evaluating Potential First-in-Class Gene Therapy for Knee Osteoarthritis (OA) Meets Primary Endpoint Showing GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms
UF startup Genascence Corporation announced positive 12-month safety and biomarker results from the Phase 1b DONATELLO clinical trial evaluating GNSC-001, a potential first-in-class gene therapy blocking interleukin 1 (IL-1) for the treatment of knee osteoarthritis (OA).